Last reviewed · How we verify
NCT01028534
Comparison of the Effects of Different Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea
NA trial testing Olmesartan and Azelnidipine in Obstructive Sleep Apnea in 150 participants. Completed in 1 December 2013.
1 December 2013
Quick facts
| Lead sponsor | Kyoto University, Graduate School of Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 July 2010 |
| Primary completion | 1 December 2013 |
| Estimated completion | 1 December 2013 |
| Sites | 2 locations across Japan |
Drugs / interventions tested
- Olmesartan and Azelnidipine — full drug profile →
Conditions studied
- Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
- Hypertension — all drugs for Hypertension →
Sponsor
Kyoto University, Graduate School of Medicine
Who can join
Adults 20 to 75, any sex, with Obstructive Sleep Apnea or Hypertension. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Blood pressure
Time frame: Six months
Sponsor's own description
The aim of the present study is to compare the effects of different types of antihypertensive drugs (angiotensin II receptor blockers and long-acting calcium channel blockers) in patients with hypertension and obstructive sleep apnea who are not controlled well with their hypertension after continuous positive airway pressure therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01028534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Sleep Apnea
Currently open trials in the same condition.
- NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
- NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
- NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
- NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
- NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting
Other Kyoto University, Graduate School of Medicine trials
Trials by the same sponsor.
- NCT07290127 — A Computer Game for Postpartum Mental Health After Emergency Cesarean Birth · NA · enrolling by invitation
- NCT07187050 — LLM-Assisted vs Manual Writing for Clinical Documentation: Effects on Time and Quality · NA · completed
- NCT04609111 — ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study · Phase 4 · active not recruiting
- NCT03462498 — ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS · Phase 4 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01028534 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kyoto University, Graduate School of Medicine
- Last refreshed: 1 April 2015
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01028534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing